Published in
Esmo Open, Esmo Open, 2(7), p. 100455, 2022
DOI: 10.1016/j.esmoop.2022.100455
Links
Tools
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials
Journal article published in 2022 by
D. König,
S. Schär,
D. Vuong,
M. Guckenberger,
K. Furrer,
I. Opitz,
W. Weder,
S. I. Rothschild,
A. Ochsenbein 
,
A. Zippelius ,
A. Addeo,
M. Mark,
E. I. Eboulet,
S. Hayoz,
S. Thierstein
and other authors.
,
A. Zippelius ,
A. Addeo,
M. Mark,
E. I. Eboulet,
S. Hayoz,
S. Thierstein
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 